| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.073 | 0.03 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.091 | 0.04 |